Clarus Wealth Advisors Danaher Corp Transaction History

Clarus Wealth Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$224.99 - $256.14 $16,199 - $18,442	72 Added 8.1%	961 $230,000
Q1 2023 Apr 10, 2023	SELL	$239.75 - $277.0 $8,391 - $9,695	-35 Reduced 3.79%	889 $224,000
Q4 2022 Jan 12, 2023	BUY	$241.42 - $282.29 $223,072 - $260,835	924 New	924 $0
Q3 2019 Oct 11, 2019	SELL	$135.4 - $146.47 $5,957 - $6,444	-44 Closed	0 $0
Q1 2019 Apr 04, 2019	SELL	$97.62 - $132.29 $488 - $661	-5 Reduced 10.2%	44 $6,000
Q4 2018 Jan 08, 2019	BUY	$94.85 - $109.54 $4,647 - $5,367	49 New	49 $5,000
Q4 2018 Jan 07, 2019	SELL	$94.85 - $109.54 $4,647 - $5,367	-49 Closed	0 $0
Q2 2018 Jul 05, 2018	BUY	$96.1 - $103.24 $4,708 - $5,058	49 New	49 $5,000

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.